About Renal Medicine Associates
Clinical Trials at Renal Medicine Associates
During the past decade, Renal Medicine Associates conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on
average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Renal Medicine Associates" #1 sponsor was "Trevi Therapeutics" with 2 trials, followed by "Ardelyx" with 1 trials
sponsored, "Bayer" with 1 trials sponsored, "Christopher Granger, MD" with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Renal Medicine Associates"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Renal Medicine Associates
According to Clinical.Site data, the most researched conditions in "Renal Medicine Associates" are
"Uremic Pruritus" (3 trials), "Pruritus" (2 trials), "Anemia" (1 trials), "Atrial Fibrillation" (1 trials) and "Chronic Kidney Disease (CKD)" (1 trials). Many other conditions were trialed in "Renal Medicine Associates" in a lesser frequency.
Clinical Trials Intervention Types at Renal Medicine Associates
Most popular intervention types in "Renal Medicine Associates" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Aprocitentan 12.5 mg" (1 trials), "Aprocitentan 25 mg" (1 trials), "BAY1213790 (Osocimab)" (1 trials) and "HX575 epoetin alfa" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Renal Medicine Associates
The vast majority of trials in "Renal Medicine Associates" are
10 trials for "All" genders.
Clinical Trials Status at Renal Medicine Associates
Currently, there are NaN active trials in "Renal Medicine Associates".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Renal Medicine Associates,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Renal Medicine Associates, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".